A retrospective analysis evaluated the incidence of ONJ in patients who received VEGF-TKIs or immune-oncology therapy for mRCC and bone-targeted therapies for bone metastases.
Using a large nationwide electronic database, researchers assessed the association between giant cell arteritis and risk for malignancies.
There was no benefit to extending zoledronate treatment beyond 2 years.
A case study of a patient who developed an acute gout flare of bilateral first metatarsophalangeal joints after initiating treatment with ibrutinib for chronic lymphocytic leukemia.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) BNT162b2 vaccine (Pfizer-BioNTech) appears to be safe and achieves satisfactory serologic status in patients with cancer.
The cumulative incidence of bone fractures was below 5% in BPA recipients.
Researchers assessed the prevalence and characteristics of musculoskeletal manifestations of childhood cancers and identified the factors that differentiated them from juvenile idiopathic arthritis.
Study authors assessed malignancy risk among patients with rheumatoid arthritis receiving combination therapy with Janus kinase inhibitors and methotrexate vs MTX alone.
A study shows 7.8% of patients with psoriasis who were treated with methotrexate developed nonmelanoma skin cancer.
The safety and efficacy of immune checkpoint inhibition in patients with advanced melanoma with and without autoimmune disease was assessed.
